Healthcare provider profile · identity verified

Michael Kalsman, MD

Family Practice · SALAMANCA, NY · NPI 1962475459

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	225	80
Amlodipine Besylate	Amlodipine Besylate	203	72
Rosuvastatin Calcium	Rosuvastatin Calcium	137	53
Ozempic	Semaglutide	128	18
Losartan Potassium	Losartan Potassium	123	44
Lisinopril	Lisinopril	121	44
Tramadol Hcl	Tramadol Hcl	102	37
Levothyroxine Sodium	Levothyroxine Sodium	99	36
Metformin Hcl	Metformin Hcl	87	30
Gabapentin	Gabapentin	85	27
Hydrochlorothiazide	Hydrochlorothiazide	80	29
Jardiance	Empagliflozin	78	16
Potassium Chloride	Potassium Chloride	78	23
Metformin Hcl Er	Metformin Hcl	74	26
Omeprazole	Omeprazole	74	32
Metoprolol Succinate	Metoprolol Succinate	73	31
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	70	12
Celecoxib	Celecoxib	64	18
Tamsulosin Hcl	Tamsulosin Hcl	61	20
Simvastatin	Simvastatin	56	20
Pantoprazole Sodium	Pantoprazole Sodium	55	18
Pregabalin	Pregabalin	52	suppressed
Allopurinol	Allopurinol	48	17
Albuterol Sulfate Hfa	Albuterol Sulfate	46	21
Trazodone Hcl	Trazodone Hcl	44	17
Fluticasone Propionate	Fluticasone Propionate	40	18
Furosemide	Furosemide	40	18
Quetiapine Fumarate	Quetiapine Fumarate	39	11
Cephalexin	Cephalexin	37	17
Zolpidem Tartrate	Zolpidem Tartrate	36	suppressed
Promethazine Hcl	Promethazine Hcl	33	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	32	11
Montelukast Sodium	Montelukast Sodium	30	suppressed
Sertraline Hcl	Sertraline Hcl	30	11
Amitriptyline Hcl	Amitriptyline Hcl	29	suppressed
Ezetimibe	Ezetimibe	29	suppressed
Bupropion Xl	Bupropion Hcl	28	suppressed
Diclofenac Sodium	Diclofenac Sodium	28	14
Chlorthalidone	Chlorthalidone	27	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	25	suppressed
Glimepiride	Glimepiride	24	suppressed
Carvedilol	Carvedilol	22	suppressed
Famotidine	Famotidine	22	suppressed
Pravastatin Sodium	Pravastatin Sodium	22	suppressed
Tizanidine Hcl	Tizanidine Hcl	22	suppressed
Clopidogrel	Clopidogrel Bisulfate	21	11
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	21	suppressed
Synthroid	Levothyroxine Sodium	21	suppressed
Hydralazine Hcl	Hydralazine Hcl	20	suppressed
Ibuprofen	Ibuprofen	20	suppressed
Clonazepam	Clonazepam	19	suppressed
Finasteride	Finasteride	19	suppressed
Eliquis	Apixaban	18	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	18	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	17	suppressed
Meloxicam	Meloxicam	17	suppressed
Trulicity	Dulaglutide	17	suppressed
Valsartan	Valsartan	17	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	16	suppressed
Mirtazapine	Mirtazapine	16	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	16	suppressed
Spironolactone	Spironolactone	16	suppressed
Valacyclovir	Valacyclovir Hcl	16	suppressed
Ibandronate Sodium	Ibandronate Sodium	15	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	15	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	15	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	15	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	15	suppressed
Prednisone	Prednisone	15	12
Alendronate Sodium	Alendronate Sodium	14	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	14	suppressed
Klor-Con M20	Potassium Chloride	14	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	14	suppressed
Alprazolam	Alprazolam	13	suppressed
Oxycodone Hcl	Oxycodone Hcl	13	suppressed
Symbicort	Budesonide/Formoterol Fumarate	13	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	13	suppressed
Atenolol	Atenolol	12	suppressed
Breo Ellipta	Fluticasone/Vilanterol	12	suppressed
Citalopram Hbr	Citalopram Hydrobromide	12	suppressed
Eplerenone	Eplerenone	12	suppressed
Telmisartan	Telmisartan	12	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	12	suppressed
Atorvaliq	Atorvastatin Calcium	11	suppressed
Bumetanide	Bumetanide	11	suppressed
Duloxetine Hcl	Duloxetine Hcl	11	suppressed
Testosterone	Testosterone	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error